MENU
NAGE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Niagen Bioscience (NAGE) Ownership - Who owns Niagen Bioscience?
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research... Show more
Industry: #Chemicals Specialty
Profile
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
515.49M
P/E Ratio
60.27
Total Cash
44.51M
Projected Growth
N/A
Total Debt
2.65M
Revenue
99.6M
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash/Share
0.57
Total Debt/Equity
N/A
Revenue/Share
1.27 USD as % of share price
Fundamentals
NAGE
Capitalization
515M
P/E Ratio
60.27
Risk (Beta)
2.47
Dividend Yield
N/A
Total Cash
44.5M
Total Cash/Share
0.57
Total Debt
2.65M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.27%
Revenue
99.6M
ROE
N/A
Book Value
46.1M
P/B Ratio
11.19
Cash Flow
N/A
Earnings
0.11
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
77K
Current Ratio
3.57
Current Revenue Per Employee
280048.06
Dividends Per Share - Security
N/A
EBITDA
9.21M
Float
N/A
Float - Current
N/A
Gross Income Margin
62.48
Revenue To Assets
13.88
Shares Held By Institutions
168M
Shares Outstanding - Current
77.8M
Total Liabilities
22.2M
Total Volume MTD
N/A
Value
-1
Gain YTD
24.976
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of proprietary-based ingredient technologies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
N/A
Phone
N/A
Employees
N/A
Web
N/A